Will Orasure Technologies stock go up?

According to Danelfin AI, Orasure Technologies has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.44%) is -2.38% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Orasure Technologies stock?

The Orasure Technologies target price is $4.37 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Orasure Technologies stock right now?

Orasure Technologies has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (48.44%) is -2.38% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Orasure Technologies stock is a good buy .

Is Orasure Technologies undervalued right now?

Based on analysts, the average price target downside for Orasure Technologies is 0.00% (1Y). According to Danelfin AI, Orasure Technologies has today an AI Score of 4/10 (Hold Rating).

What was the price range of Orasure Technologies stock over the past 12 months?

The Orasure Technologies stock price range over the past 12 months has been $2.11 - $4.5.

What is going on with Orasure Technologies stock in the last 3 months?

The Orasure Technologies stock performance in the last quarter has been +43.27%.

Does Orasure Technologies offer dividend payments?

No, Orasure Technologies does not currently pay dividends.

What is the current market capitalization of Orasure Technologies?

Orasure Technologies's market cap is $299.5M, as of 2026-07-03 08:00.

OraSure Technologies Inc (OSUR) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

OSUR AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+6.63%
How the stock is priced relative to its fundamentals
Earnings Quality+3.61%
Stability and reliability of reported earnings
Size & Liquidity+0.83%
Company size and trading liquidity
Momentum+0.80%
Direction and strength of recent price movements
Volatility+0.56%
How much the stock price tends to fluctuate

Sentiment-10.68%
How analysts and the market view the stock
Financial Strength-2.36%
Balance sheet strength and financial resilience
Profitability-1.77%
Profitability and operating efficiency metrics

OSUR probability advantage of beating the market (3M):

-2.38%

AI Score

Hold

Orasure Technologies (OSUR) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -2.38% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of OSUR (48.44%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
OSUR probability advantage of beating the market (3M)-2.38%
OSUR probability of beating the market (3M)48.44%

OSUR probability advantage of beating the market (3M): -2.38%

The AI-powered overall analysis of Orasure Technologies (OSUR) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of OSUR:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-7.25%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+6.27%
Fundamental	Operating Cash Flow (Qtr Discrete)	-10.07		+2.89%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-2.60%
Fundamental	Long-Term Debt Coverage Ratio	-118.76	N/A	-2.36%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-2.25%
Technical	Chart Pattern (120d)	figure_156	N/A	-2.08%
Fundamental	Operating Profit Margin	-83.33%		-1.77%
Technical	Technicals Impact (Long Tail)	-	N/A	+1.73%
Sentiment	Earnings Countdown	-51		+1.31%
Fundamental	Upgrade to unlock			+1.17%
Technical	Upgrade to unlock			-1.11%
Technical	Upgrade to unlock			-1.04%
Technical	Upgrade to unlock			+1.04%
Technical	Upgrade to unlock			+1.03%

Rest of Alpha Signals: +2.66%

OSUR probability advantage of beating the market (3M)Total:-2.38%
OSUR AI Score

Significant changes Vs previous day

OSUR Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$4.37
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

OSUR Proven Hold Signal & Price Forecast

This is the price chart for OSUR from January 2, 2026 until today. The chart indicates, in yellow, the 89 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

OSUR Average Past Performance & Win Rate

Three months after its 1523 Hold signals since July 2026, OSUR had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1523 Past OSUR Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-11.15%
Average Alpha				-23.88%
Win Rate (% Positive Perf.)				29.63%
% Positive Alpha				25.23%

OSUR Frequently Asked Questions

Will Orasure Technologies stock go up?
According to Danelfin AI, Orasure Technologies has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.44%) is -2.38% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Orasure Technologies stock?
Is it a good time to buy, sell, or hold Orasure Technologies stock right now?
Is Orasure Technologies undervalued right now?
What was the price range of Orasure Technologies stock over the past 12 months?
What is going on with Orasure Technologies stock in the last 3 months?
Does Orasure Technologies offer dividend payments?
What is the current market capitalization of Orasure Technologies?

OraSure Technologies Inc Company Profile

OraSure Technologies, Inc., along with its affiliated entities, is a global provider of point-of-care and home diagnostic solutions, specimen collection instruments, and microbiome lab analysis services. The company's key products encompass the InteliSwab series of rapid COVID-19 tests, the OraQuick line covering Rapid HIV testing, HCV antibody testing and Ebola antigen detection. The latter also includes an oral fluid collection device in alliance with screenings and confirmatory procedures for HIV-1 antibodies.

The company proffers Intercept drug detection apparatuses; immunoassay evaluations and reagent substances; plus the saliva alcohol Q.E.D. test. Complementing these are their genomics-oriented Oragene and ORAcollect collections designed for extracting genetic material from salivary samples. This extends to their Colli-Pee range for collecting proportionate samples of urine voids.

In alignment with advancing microbiome science, OraSure provides analysis services as well as lab tests. Their product selection includes OMNIgene GUT devices created for amassing microbial DNA from stool or fecal specimens aimed at gut microbiome profiling. This portfolio also comprises DNA and RNA collection apparatuses along with an OMNIgene GUT Dx device tailor-made for fecal sample procurement while stabilising bacterial community DNA.

The organization also supplies additional diagnostic solutions such as immunoassays and other in vitro assessment techniques. They channel their product offerings to an array of customers including hospitals, clinical labs, physicians' offices, public health organizations, government bodies, disease risk management firms as well as enterprises in pharmaceuticals, biotech, diagnostics industry itself besides nutrition companies.

Founded in 2000 with its base in Bethlehem, Pennsylvania; Today OraSure Technologies extends its prowess internationally across Europe and beyond while constantly demonstrating its dedication to improving global health outcomes.

Sector:Health Care
Country:United States
Industry:Health Care Equipment & Supplies
Address:220 E First St, Bethlehem
Employees:500
Website:orasure.com

Pros

Proprietary oral fluid collection and testing platforms

High switching costs for integrated laboratory workflows

Regulatory barriers to entry for diagnostic test approvals

Recurring revenue from consumable diagnostic kits

Diversified product portfolio across diagnostic segments

Cons

Intense competition from established diagnostic companies

Ongoing regulatory compliance costs and risks

Demand cyclicality in public health testing programs

Reliance on specific healthcare distribution channels

Risk of technology disruption from novel diagnostic methods

Company	AI Score	Compare
QDELQuidelOrtho Corp
DGXQuest Diagnostics Inc
TRIBTrinity Biotech PLC
GHGuardant Health Inc
BLLNBillionToOne Inc

Company	AI Score	Compare
QDELQuidelOrtho Corp
DGXQuest Diagnostics Inc
TRIBTrinity Biotech PLC
GHGuardant Health Inc
BLLNBillionToOne Inc

OSUR Stock AI Analysis